DE3873410D1 - Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung. - Google Patents

Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung.

Info

Publication number
DE3873410D1
DE3873410D1 DE8888107564T DE3873410T DE3873410D1 DE 3873410 D1 DE3873410 D1 DE 3873410D1 DE 8888107564 T DE8888107564 T DE 8888107564T DE 3873410 T DE3873410 T DE 3873410T DE 3873410 D1 DE3873410 D1 DE 3873410D1
Authority
DE
Germany
Prior art keywords
drug delivery
oral drug
formulation
production
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8888107564T
Other languages
English (en)
Other versions
DE3873410T2 (de
Inventor
Edward Anthony Newsham
Jeffrey Wilfred Forrester
Duncan John Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21976676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3873410(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of DE3873410D1 publication Critical patent/DE3873410D1/de
Publication of DE3873410T2 publication Critical patent/DE3873410T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DE8888107564T 1987-05-21 1988-05-11 Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung. Revoked DE3873410T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/052,297 US4867970A (en) 1987-05-21 1987-05-21 Moistureless oral drug delivery formulation and method for preparing same

Publications (2)

Publication Number Publication Date
DE3873410D1 true DE3873410D1 (de) 1992-09-10
DE3873410T2 DE3873410T2 (de) 1993-01-21

Family

ID=21976676

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888107564T Revoked DE3873410T2 (de) 1987-05-21 1988-05-11 Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung.

Country Status (13)

Country Link
US (1) US4867970A (de)
EP (1) EP0291838B1 (de)
JP (1) JPS63303924A (de)
AT (1) ATE79023T1 (de)
AU (1) AU1372888A (de)
CA (1) CA1314479C (de)
DE (1) DE3873410T2 (de)
DK (1) DK278288A (de)
ES (1) ES2034010T3 (de)
GR (1) GR3006146T3 (de)
HU (1) HU199071B (de)
IE (1) IE63548B1 (de)
ZA (1) ZA882290B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
JPH07508975A (ja) * 1992-04-23 1995-10-05 バーレックス　ラボラトリーズ　インコーポレイテッド 生体接着性水性鉱油エマルション軟膏基剤，それからなる局所医薬組成物及び創傷治癒におけるその使用
US5310961A (en) * 1993-07-02 1994-05-10 Affinity Biotech, Inc. Neomorphic ibuprofen
EP0788801A1 (de) * 1994-07-20 1997-08-13 Toyama Chemical Co., Ltd. Orale salbe mit verzögerter freisetzung
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
JP4653282B2 (ja) * 2000-05-23 2011-03-16 昭和薬品化工株式会社 ミノサイクリン含有組成物
ATE480226T1 (de) 2001-06-22 2010-09-15 Bend Res Inc Pharmazeutische zusammensetzung enthaltend schwer lösliche und säureempfindliche arzneistoffe und neutralisierte anionische polymere
DE10157260B4 (de) * 2001-11-22 2005-12-15 Pharmoxid Arznei Gmbh + Co. Kg Streichfähige Salbe mit Ozoniden und Peroxiden von Fettsäuren oder deren Estern
US20040091551A1 (en) * 2002-11-13 2004-05-13 Al-Karim Damji Topical composition and application system
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
JP2005097271A (ja) * 2003-08-20 2005-04-14 Matsumoto Shika Univ 抗真菌剤用組成物
US20050054583A1 (en) * 2003-08-20 2005-03-10 Matsumoto Dental University Composition for an antifungal agent for suppressing fungal growth in an oral cavity
EP1510205B1 (de) * 2003-09-01 2008-03-26 JPM - The Jordanian Pharmaceutical Manufacturing Co. Ltd. Universelle Zusammensetzung zur kontrollierten Wirkstofffreigabe enthaltend Xanthangummi und Natriumalginat
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
WO2006031848A2 (en) * 2004-09-15 2006-03-23 Ivax Corporation Corticosteroid topical dispersion with low content of surfactant
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
CA2845634C (en) 2011-08-18 2021-07-13 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628187A (en) 1950-05-06 1953-02-10 Res Prod Corp Medicinal mineral oil vehicle thickened with polyethylene
US3029188A (en) * 1958-02-20 1962-04-10 Olin Mathieson Gelatin adhesive pharmaceutical preparations
US3029187A (en) * 1958-02-20 1962-04-10 Steinhardt Amos Gelating adhesive pharmaceutical preparations
FR1367858A (fr) * 1962-08-11 1964-07-24 Hoechst Ag Bases de pommades pour les muqueuses et leur préparation
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
GB1063185A (en) * 1965-04-27 1967-03-30 Astra Ab Improvements in the administration of veterinary medicines
US3594467A (en) * 1968-10-09 1971-07-20 Richardson Merrell Inc Long-lasting troche
US3984571A (en) * 1970-03-10 1976-10-05 E. R. Squibb & Sons, Inc. Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
JPS5386011A (en) * 1977-10-31 1978-07-29 Nippon Kayaku Co Ltd Preparation of paste
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
JPS6043328B2 (ja) * 1981-04-16 1985-09-27 昭和薬品化工株式会社 軟膏の基剤
JPS58206534A (ja) * 1982-05-26 1983-12-01 Taisho Pharmaceut Co Ltd 口腔薬基剤
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
EP0256611A1 (de) * 1986-08-08 1988-02-24 Squibb Japan Inc. System zur oralen Arzneistoffzufuhr

Also Published As

Publication number Publication date
ES2034010T3 (es) 1993-04-01
ATE79023T1 (de) 1992-08-15
HU199071B (en) 1990-01-29
GR3006146T3 (de) 1993-06-21
DK278288A (da) 1988-11-22
HUT49280A (en) 1989-09-28
IE881540L (en) 1988-11-21
DK278288D0 (da) 1988-05-20
JPS63303924A (ja) 1988-12-12
EP0291838A3 (en) 1989-05-31
CA1314479C (en) 1993-03-16
AU1372888A (en) 1988-11-24
IE63548B1 (en) 1995-05-17
DE3873410T2 (de) 1993-01-21
ZA882290B (en) 1988-09-22
EP0291838B1 (de) 1992-08-05
US4867970A (en) 1989-09-19
EP0291838A2 (de) 1988-11-23

Similar Documents

Publication Publication Date Title
DE3873410D1 (de) Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung.
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
NO2000010I1 (no) Farmasøytisk akseptable salter av esomeprazol
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
IT1178235B (it) Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione
ES8608864A1 (es) Un procedimiento para producir un preparado a modo de hojas
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EE03039B1 (et) Meetod hüdrateeritud tsefalosporiini kuiva pulbrilise segu valmistamiseks, sellel meetodil valmistatud segu ja farmatseutilised kompositsioonid
IL74446A (en) Transdermal pharmaceutical compositions for systemic administration containing bopindolol or methysergide
EP0173664A3 (de) Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung
AT382076B (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
IT1215340B (it) Derivati di esteri dell'acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ATE91414T1 (de) Hustenstillende zusammensetzungen und ein verfahren zu deren herstellung.
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
IT8222500A0 (it) Derivati dell'acido 7 bet5a-amino-3-metossi-3-cefem-4-carbossilico,procedimenti per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8222854A0 (it) Derivati dell'acido lattobionico, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
ES8401483A1 (es) Procedimiento para preparar nuevas furobenzazepinas.
GR920100437A (el) Φαρμακευτικά σκευάσματα βραδείας απελευ?έρωσης χορηγούμενα από του στόματος και περιέχοντα χολικά οξέα.
ATE53846T1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
IT8222843A0 (it) Derivati dell'acido 5-tiazolil-acetico, procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali derivati.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation